Today: 22 March 2026
Subscribe
Browse Category

NASDAQ:REVB 23 January 2026

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences shares rose about 2% premarket after an SEC filing showed FDA agreement on a single adaptive Phase 2/3 trial for its Gemini program in acute kidney injury. The company said strong results from roughly 300 patients could support a U.S. approval filing. Shares last traded near $0.85. Investors remain focused on trial timing and the firm’s $12.7 million cash position.
23 January 2026
··

Stock Market Today

  • Bitcoin Miners Face $19,000 Loss Per BTC Amid Falling Difficulty and Rising Costs
    March 22, 2026, 5:18 AM EDT. Bitcoin miners are losing about $19,000 on every BTC produced, driven by a network difficulty drop of 7.8% and surging energy costs tied to the Middle East conflict. The average cost to mine one bitcoin stands at $88,000, while the market price is near $69,200, pushing miners into an average 21% loss. Mining difficulty has fallen nearly 10% since the year's start, with hashrate retreating from last year's peak. Rising oil prices, disruption at the Strait of Hormuz, and geopolitical risks elevate mining expenses. Miners are coping by diversifying into AI and computing sectors. The next difficulty adjustment in April may decrease further, signaling continued stress and a shrinking miner base, impacting bitcoin's market structure beyond just the mining sector.
Go toTop